当前位置:首页 - 行情中心 - 海创药业-U(688302) - 财务分析 - 利润表

海创药业-U

(688302)

  

流通市值:46.00亿  总市值:55.87亿
流通股本:8151.51万   总股本:9901.56万

利润表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、营业总收入13,167,136.01-366,836.28109,734.51
  营业收入13,167,136.01-366,836.28109,734.51
二、营业总成本85,364,215.9136,727,239.36217,539,778.96167,129,902.63
  营业成本62,643.88-335,91896,520.22
  税金及附加376,732.2986,848.79411,284.78335,459.57
  销售费用10,500,524.533,901,495.511,353,420.858,060,379.44
  管理费用21,421,965.7310,121,852.8242,140,341.4231,408,401.17
  研发费用56,967,171.9124,765,858.75174,031,725.15133,308,299.09
  财务费用-3,964,822.43-2,148,816.5-10,732,911.24-6,079,156.86
  其中:利息费用195,045.1205,515.51526,607.32386,144.54
  其中:利息收入4,571,463.992,456,849.1610,013,732.897,707,333.76
三、其他经营收益
  加:公允价值变动收益2,054,220.431,535,554.133,962,834.763,476,139.91
  加:投资收益1,843,351.31,920,474.119,144,656.326,944,387.25
  信用减值损失(新)-806,540.25-731,402.59-324,710.27-313,071.13
  其他收益7,494,467.561,902,857.494,908,617.332,852,236.87
四、营业利润-61,611,580.86-32,099,756.22-199,481,544.54-154,060,475.22
  加:营业外收入--1101.75
  减:营业外支出239,605.3-2,073.62,072.96
五、利润总额-61,851,186.16-32,099,756.22-199,483,508.14-154,062,546.43
  减:所得税费用2,014.82,012.5512,227.968,886.5
六、净利润-61,853,200.96-32,101,768.77-199,495,736.1-154,071,432.93
(一)按经营持续性分类
  持续经营净利润-61,853,200.96-32,101,768.77-199,495,736.1-154,071,432.93
(二)按所有权归属分类
  归属于母公司股东的净利润-61,853,200.96-32,101,768.77-199,495,736.1-154,071,432.93
  扣除非经常损益后的净利润-73,005,634.95-37,460,654.5-217,509,880.91-167,342,125.75
七、每股收益
  (一)基本每股收益-0.62-0.32-2.01-1.56
八、其他综合收益-39,554.47-12,510.77-139,265.41-50,937.38
  归属于母公司股东的其他综合收益-39,554.47-12,510.77-139,265.41-50,937.38
九、综合收益总额-61,892,755.43-32,114,279.54-199,635,001.51-154,122,370.31
  归属于母公司股东的综合收益总额-61,892,755.43-32,114,279.54-199,635,001.51-154,122,370.31
公告日期2025-08-142025-04-262025-04-192024-10-26
审计意见(境内)标准无保留意见
TOP↑